-
-
-
-
-
-
-
NeoGenomics stock surges following earnings, two upgrades
-
-
-
-
-
-
-
Leerink Partners Reiterates Market Perform Rating on Neogenomics (NEO) amid test reimbursements
-
-
-
-
-
-
-
Natera withdraws appeal in NeoGenomics patent case
-
-
-
-
-
-
-
NeoGenomics (NEO) call put ratio 21 calls to 1 put with a focus on September calls
-
-
-
-
-
-
-
NeoGenomics (NEO) Tops Q2 EPS by 1c; offers guidance
-
-
-
-
-
-
-
NeoGenomics (NEO) Tops Q1 EPS by 1c, provides guidance
-
-
-
-
-
-
-
TD Cowen: 'Top 10 Themes Coming Out of 45th Annual Health Care Conference'
-
445,853 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

